Concepedia

Author

Despina Siolas

Cornell UniversityORCID

Also Known As

D. Siolas, Despina Siolas

53

Publications

2.2K

Citations

11

H-Index

33

Concepts

All Affiliations

Cornell UniversityPresbyterian HospitalNYU Langone HealthWeill Cornell MedicineNew York Hospital Queens
DS

About

Despina Siolas is an author at Cornell University specializing in medicine, cancer research, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

710

2

Pathology

3

3

77

3

Cell Biology

2

2

63

4

Immunology

2

2

30

5

Health Sciences

1

1

17

Despina Siolas

×

9

Publications

991

Citations

9

H-Index

YearCitations

Second-generation shRNA libraries covering the mouse and human genomes

José M. Silva, Mamie Z. Li, Ken C. N. Chang,

Nature Genetics

2005

617

Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer

Jane Cullis, Despina Siolas, Antonina Avanzi,

Cancer Immunology Research

2017

154

Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy

Despina Siolas, Emily Vucic, Emma Kurz,

Cell Reports

2021

78

Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer

Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park,

Cancer Cell

2024

47

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer

Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D. Jafari,

Oncogene

2023

37

Neoadjuvant botensilimab plus balstilimab in resectable mismatch repair proficient and deficient colorectal cancer: NEST-1 clinical trial.

Pashtoon Murtaza Kasi, Mehraneh D. Jafari, Heather Yeo,

Journal of Clinical Oncology

2024

17

Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)

Nancy Liu-Sullivan, Jianping Zhang, Amy Bakleh,

Oncotarget

2011

16

The Achilles’ Heel of Pancreatic Cancer: Targeting pancreatic cancer's unique immunologic characteristics and metabolic dependencies in clinical trials

Despina Siolas, C. Morrissey, Paul E. Oberstein

Journal of Pancreatology

2020

13

Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205).

Kian‐Huat Lim, Kristen Spencer, Rachael A. Safyan,

Journal of Clinical Oncology

2024

12

Page 1